
A Breakthrough in Pancreatic Cancer Treatment – KRAS Targeting and Daraxonrasib
Aug 28, 2026 - 00:32:13
Radio and PodcastLive Radio & Podcasts
Tumor-infiltrating lymphocyte, or TIL, therapy is a new form of cellular immunotherapy that targets cancer cells by leveraging the body’s immune system and specialized cells called T-lymphocytes. This treatment is curren...